duloxetine hydrochloride has been researched along with mk 0663 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gahn, J; Han, B; Happich, M; Myers, J; Paget, MA; Price, K; Wielage, RC | 1 |
| Attia, JZ; Mansour, HS | 1 |
1 review(s) available for duloxetine hydrochloride and mk 0663
| Article | Year |
|---|---|
The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.
Topics: Acetaminophen; Administration, Oral; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Bayes Theorem; Drug Evaluation; Duloxetine Hydrochloride; Etoricoxib; Humans; Narcotics; Osteoarthritis; Pain Measurement; Pyridines; Sulfones; Thiophenes; Treatment Outcome | 2014 |
1 trial(s) available for duloxetine hydrochloride and mk 0663
| Article | Year |
|---|---|
Perioperative Duloxetine and Etoricoxibto improve postoperative pain after lumbar Laminectomy: a randomized, double-blind, controlled study.
Topics: Adult; Analgesics; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Etoricoxib; Female; Humans; Laminectomy; Lumbar Vertebrae; Male; Middle Aged; Pain, Postoperative; Perioperative Care; Prospective Studies; Pyridines; Sulfones | 2017 |
1 other study(ies) available for duloxetine hydrochloride and mk 0663
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |